Abhinav Srinath

Abhinav Srinath

Auto-generated profile, based on publicly available information

Abhinav Srinath

Neurovascular Surgery Program, Department of Neurological Surgery, The University of Chicago, 5841S. Maryland Avenue, Chicago, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2022 in Circulation Research
Verified
Journal Article
Closed access
PDF file
JMJessica Magid-Bernstein
Jessica Magid-Bernstein
RGRomuald Girard
Romuald Girard
SPSean P Polster
Sean P Polster
ASAbhinav Srinath
Abhinav Srinath
SRSharbel Romanos
Sharbel Romanos
LSLauren H. Sansing
Lauren H. Sansing
Intracerebral hemorrhage (ICH) is a devastating form of stroke with high morbidity and mortality. This review article focuses on the epidemiology, cause, mechanisms of injury, current treatment strategies, and future research directions of ICH. Incidence of hemorrhagic stroke has increased worldwide over the past 40 years, with shifts in the cause over time as hypertension management has improved and anticoagulant use has increased. Preclinical and clinical trials have elucidated the underlying ICH cause and mechanisms of injury from ICH including the complex interaction between edema, inflammation, iron-induced injury, and oxidative stress. Several trials have investigated optimal medical and surgical management of ICH without clear improvement in survival and functional outcomes. Ongoing research into novel approaches for ICH management provide hope for reducing the devastating effect of this disease in the future. Areas of promise in ICH therapy include prognostic biomarkers and primary prevention based on disease pathobiology, ultra-early hemostatic therapy, minimally invasive surgery, and perihematomal protection against inflammatory brain injury.

2 December 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
HDHemraj B. Dodiya
Hemraj B. Dodiya
HLHolly L. Lutz
Holly L. Lutz
IWIan Q. Weigle
Ian Q. Weigle
PPPriyam Patel
Priyam Patel
JMJulia Michalkiewicz
Julia Michalkiewicz
SSSangram S. Sisodia
Sangram S. Sisodia
We previously demonstrated that lifelong antibiotic (ABX) perturbations of the gut microbiome in male APPPS1-21 mice lead to reductions in amyloid β (Aβ) plaque pathology and altered phenotypes of plaque-associated microglia. Here, we show that a short, 7-d treatment of preweaned male mice with high-dose ABX is associated with reductions of Aβ amyloidosis, plaque-localized microglia morphologies, and Aβ-associated degenerative changes at 9 wk of age in male mice only. More importantly, fecal microbiota transplantation (FMT) from transgenic (Tg) or WT male donors into ABX-treated male mice completely restored Aβ amyloidosis, plaque-localized microglia morphologies, and Aβ-associated degenerative changes. Transcriptomic studies revealed significant differences between vehicle versus ABX-treated male mice and FMT from Tg mice into ABX-treated mice largely restored the transcriptome profiles to that of the Tg donor animals. Finally, colony-stimulating factor 1 receptor (CSF1R) inhibitor-mediated depletion of microglia in ABX-treated male mice failed to reduce cerebral Aβ amyloidosis. Thus, microglia play a critical role in driving gut microbiome–mediated alterations of cerebral Aβ deposition.

14 March 2022 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
DSDaniel A. Snellings
Daniel A. Snellings
RGRomuald Girard
Romuald Girard
RLRhonda Lightle
Rhonda Lightle
ASAbhinav Srinath
Abhinav Srinath
SRSharbel Romanos
Sharbel Romanos
DMDouglas A. Marchuk
Douglas A. Marchuk

3 March 2023 in Communications Medicine
Verified
Journal Article
Open access
PDF file
ASAbhinav Srinath
Abhinav Srinath
BXBingqing Xie
Bingqing Xie
YLYing Li
Ying Li
JSJe Yeong Sone
Je Yeong Sone
SRSharbel Romanos
Sharbel Romanos
RGRomuald Girard
Romuald Girard
Background: Cavernous angiomas (CAs) affect 0.5% of the population, predisposing to serious neurologic sequelae from brain bleeding. A leaky gut epithelium associated with a permissive gut microbiome, was identified in patients who develop CAs, favoring lipid polysaccharide producing bacterial species. Micro-ribonucleic acids along with plasma levels of proteins reflecting angiogenesis and inflammation were also previously correlated with CA and CA with symptomatic hemorrhage. Methods: The plasma metabolome of CA patients and CA patients with symptomatic hemorrhage was assessed using liquid-chromatography mass spectrometry. Differential metabolites were identified using partial least squares-discriminant analysis (p < 0.05, FDR corrected). Interactions between these metabolites and the previously established CA transcriptome, microbiome, and differential proteins were queried for mechanistic relevance. Differential metabolites in CA patients with symptomatic hemorrhage were then validated in an independent, propensity matched cohort. A machine learning-implemented, Bayesian approach was used to integrate proteins, micro-RNAs and metabolites to develop a diagnostic model for CA patients with symptomatic hemorrhage. Results: Here we identify plasma metabolites, including cholic acid and hypoxanthine distinguishing CA patients, while arachidonic and linoleic acids distinguish those with symptomatic hemorrhage. Plasma metabolites are linked to the permissive microbiome genes, and to previously implicated disease mechanisms. The metabolites distinguishing CA with symptomatic hemorrhage are validated in an independent propensity-matched cohort, and their integration, along with levels of circulating miRNAs, enhance the performance of plasma protein biomarkers (up to 85% sensitivity and 80% specificity). Conclusions: Plasma metabolites reflect CAs and their hemorrhagic activity. A model of their multiomic integration is applicable to other pathologies.

17 June 2022 in Translational Stroke Research
Verified
Journal Article
Closed access
PDF file
SRSharbel G. Romanos
Sharbel G. Romanos
ASAbhinav Srinath
Abhinav Srinath
YLYing Li
Ying Li
BXBingqing Xie
Bingqing Xie
CCChang Chen
Chang Chen
IAIssam A. Awad
Issam A. Awad

8 September 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
ASAbdallah Shkoukani
Abdallah Shkoukani
ASAbhinav Srinath
Abhinav Srinath
ASAgnieszka Stadnik
Agnieszka Stadnik
RGRomuald Girard
Romuald Girard
RSRobert Shenkar
Robert Shenkar
IAIssam A. Awad
Issam A. Awad